Topic · Drug-Induced Adverse Reactions
Most cited papers in Drug-Induced Adverse Reactions
What are the most cited papers in Drug-Induced Adverse Reactions?
The most cited paper in Drug-Induced Adverse Reactions is "Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients" (Munir Pirmohamed, Sally James, Shaun Meakin et al., 2004), with 3,262 citations. Next come "Sarcoidosis" (1,973) and "HLA-B*5701 Screening for Hypersensitivity to Abacavir" (1,847).
Showing 50 of 100 papers. Every paper with more than 542 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients Munir Pirmohamed, Sally James, Shaun Meakin et al. · BMJ | Jul 2004 | 3,262 |
| 2 | Sarcoidosis Michael C. Iannuzzi, Benjamin A. Rybicki, Alvin S. Teirstein · New England Journal of Medicine | 21 Nov 2007 | 1,973 |
| 3 | HLA-B*5701 Screening for Hypersensitivity to Abacavir Simon Alexander Mallal, Elizabeth Jane Phillips, Giampiero Carosi et al. · New England Journal of Medicine | 6 Feb 2008 | 1,847 |
| 4 | A marker for Stevens–Johnson syndrome Wen‐Hung Chung, Wen‐Hung Chung, Hong‐Shang Hong et al. · Nature | Apr 2004 | 1,760 |
| 5 | Cremophor EL Hans A. J. Gelderblom, Jaap Verweij, Kees Nooter et al. · European Journal of Cancer | Sep 2001 | 1,658 |
| 6 | Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme Sylvie Bastuji‐Garin · Archives of Dermatology | 1993 | 1,632 |
| 7 | Severe Adverse Cutaneous Reactions to Drugs Jean Claude Roujeau, Robert S. Stern · New England Journal of Medicine | 10 Nov 1994 | 1,578 |
| 8 | Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis Jean‐Claude Roujeau, Judith Parsells Kelly, Luigi Naldi et al. · New England Journal of Medicine | 14 Dec 1995 | 1,473 |
| 9 | European Society of Contact Dermatitis guideline for diagnostic patch testing – recommendations on best practice Jeanne Duus Johansen et al. · Contact Dermatitis | 14 Jul 2015 | 1,448 |
| 10 | Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin Francesca Catella-Lawson, Muredach P. Reilly, Shiv C. Kapoor et al. · New England Journal of Medicine | 20 Dec 2001 | 1,412 |
| 11 | Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir Simon Alexander Mallal, David A Nolan, Campbell S. Witt et al. · The Lancet | Mar 2002 | 1,387 |
| 12 | A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions Eugène van Puijenbroek, Andrew M. Bate, Hubert G.M. Leufkens et al. · Pharmacoepidemiology and Drug Safety | 2002 | 1,385 |
| 13 | HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol Wen‐Hung Chung, Wen‐Hung Chung, Lieh-Bang Liou et al. · Proceedings of the National Academy of Sciences | 2 Mar 2005 | 1,295 |
| 14 | Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up John B.A.G. Haanen, Michel Obéid, Lavinia Anne Spain et al. · Annals of Oncology | 18 Oct 2022 | 1,285 |
| 15 | Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs Sherine E. Gabriel, Liisa Jaakkimainen, Claire Bombardier · Annals of Internal Medicine | 15 Nov 1991 | 1,248 |
| 16 | Sarcoidosis Lee Scott Newman, Cecile Stephanie Rose, Lisa A. Maier · New England Journal of Medicine | 24 Apr 1997 | 1,241 |
| 17 | SCORTEN: A Severity-of-Illness Score for Toxic Epidermal Necrolysis Nathalie Fouchard, M. Bertocchi, Jean‐Claude Roujeau et al. · Journal of Investigative Dermatology | Aug 2000 | 1,202 |
| 18 | Diagnostic criteria and classification of mastocytosis: a consensus proposal Peter Valent, Hans‐P. Horny, Luís Escribano et al. · Leukemia Research | Jul 2001 | 1,117 |
| 19 | Cytokine modulation of atopic dermatitis filaggrin skin expression Michael D Howell, Byung Eui Kim, Peisong Gao et al. · Journal of Allergy and Clinical Immunology | 25 May 2007 | 1,098 |
| 20 | Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology Antonella Maria Muraro et al. · Allergy | 9 Jun 2014 | 1,059 |
| 21 | Racial Differences in Sarcoidosis Incidence: A 5-Year Study in a Health Maintenance Organization Benjamin A. Rybicki, Marcie L. Major, John Popovich et al. · American Journal of Epidemiology | Feb 1997 | 1,024 |
| 22 | Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study Maja Mockenhaupt, Cecile G. Viboud, Ariane Dunant et al. · Journal of Investigative Dermatology | 6 Sep 2007 | 1,020 |
| 23 | Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study Sylvia Helena Kardaun, Peggy Sekula, L. Valeyrie‐Allanore et al. · British Journal of Dermatology | 16 Jul 2013 | 1,018 |
| 24 | The DRESS Syndrome: A Literature Review P. Cacoub, Philippe Musette, Vincent Descamps et al. · The American Journal of Medicine | 22 May 2011 | 1,017 |
| 25 | Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin I. Viard, Philippe Wehrli, Roberto R. Bullani et al. · Science | 16 Oct 1998 | 1,011 |
| 26 | Clinical features and severity grading of anaphylaxis Simon G.A. Brown · Journal of Allergy and Clinical Immunology | Aug 2004 | 1,005 |
| 27 | Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs La García Rodríguez, Hershel Jick · The Lancet | Mar 1994 | 978 |
| 28 | Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2 Makoto Murakami, Hiroaki Naraba, Toshihiro Tanioka et al. · Journal of Biological Chemistry | Oct 2000 | 971 |
| 29 | Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS) Hélène Bocquet, Martine Bagot, Jean Claude Roujeau · Seminars in Cutaneous Medicine and Surgery | Dec 1996 | 967 |
| 30 | Adverse Effects of Nonsteroidal Antiinflammatory Drugs: An Update of Gastrointestinal, Cardiovascular and Renal Complications Sam Harirforoosh, Waheed Asghar, Fakhreddin Jamali · Journal of Pharmacy & Pharmaceutical Sciences | 27 Jan 2014 | 967 |
| 31 | International Con sensus on drug allergy Pascal M. Demoly, N. Franklin Adkinson, Knut Brockow et al. · Allergy | 21 Feb 2014 | 937 |
| 32 | Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Sylvia Helena Kardaun, Alexis Sidoroff, L. Valeyrie‐Allanore et al. · British Journal of Dermatology | 19 Jan 2007 | 933 |
| 33 | HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans Mark McCormack et al. · New England Journal of Medicine | 23 Mar 2011 | 926 |
| 34 | Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs Michael J. S. Langman, J Weil, Paul Wainwright et al. · The Lancet | Apr 1994 | 878 |
| 35 | Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials Yucai Wang, Shouhao Zhou, Fang Yang et al. · JAMA Oncology | 25 Apr 2019 | 873 |
| 36 | Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies Joseph A. Kovacs, JOHN W. HIEMENZ, ABE M. MACHER et al. · Annals of Internal Medicine | May 1984 | 859 |
| 37 | Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis Wen‐Hung Chung, Wen‐Hung Chung, Jui‐Yung Yang et al. · Nature Medicine | 23 Nov 2008 | 838 |
| 38 | Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: A cohort study Eric M. Macy, Richard Contreras · Journal of Allergy and Clinical Immunology | Nov 2013 | 834 |
| 39 | Evaluation and Management of Penicillin Allergy Erica Seiguer Shenoy, Eric M. Macy, Theresa A. Rowe et al. · JAMA | 15 Jan 2019 | 828 |
| 40 | Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations Werner Aberer, Andreas J. Bircher, Antonino G. Romano et al. · Allergy | 4 Aug 2003 | 822 |
| 41 | Acute generalized exanthematous pustulosis (AGEP) – A clinical reaction pattern Alexis Sidoroff, Sima Halevy, Jan Nico Bouwes Bavinck et al. · Journal of Cutaneous Pathology | Mar 2001 | 815 |
| 42 | Genetic variations in HLA-B region and hypersensitivity reactions to abacavir Seth Hetherington, Arlene R. Hughes, Michael Mosteller et al. · The Lancet | Mar 2002 | 813 |
| 43 | Skin test concentrations for systemically administered drugs – an ENDA / EAACI Drug Allergy Interest Group position paper Knut Brockow et al. · Allergy | 25 Apr 2013 | 812 |
| 44 | Use of Nonsteroidal Antiinflammatory Drugs Elliott Marshall Antman, JOEL S. BENNETT, Alan Daugherty et al. · Circulation | 27 Feb 2007 | 811 |
| 45 | Manifestations of sarcoidosis Robert L. Mayock, Pierre Bertrand, Claire E. Morrison et al. · The American Journal of Medicine | Jul 1963 | 807 |
| 46 | Tetracyclines: Nonantibiotic properties and their clinical implications Allen N. Sapadin, Raúl Fleischmajer · Journal of the American Academy of Dermatology | 27 Jan 2006 | 775 |
| 47 | Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations Faviel F. González-Galarza, Louise Y.C. Takeshita, Eduardo José Melo dos Santos et al. · Nucleic Acids Research | 20 Nov 2014 | 765 |
| 48 | ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis Bruno Sassolas, Cynthia Haddad, Maja Mockenhaupt et al. · Clinical Pharmacology & Therapeutics | 7 Apr 2010 | 755 |
| 49 | Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria Peter Valent et al. · European Journal of Clinical Investigation | 26 May 2007 | 751 |
| 50 | Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials Philippe Gevaert, Theodore A. Omachi, Jonathan Corren et al. · Journal of Allergy and Clinical Immunology | 7 Jun 2020 | 740 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.